CD151 is correlated with poor prognosis in endometrial cancer [39], accelerates breast cancer cell invasion via integrin α6 [40], and promotes prostate cancer migratory activity and lymphangiogenesis, increasing metastatic potential [41]. Here, CD151 is linked to prostate carcinoma.